{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:55:05Z","timestamp":1781636105142,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100015763","name":"University of Szeged","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100015763","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    This prospective, single-center, single-blind, interventional cohort study compares acute intraocular pressure (IOP) changes following intravitreal aflibercept injections in eyes with different vitreous states. 67 eyes of 58 patients, including vitrectomized eyes with (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200922) and without silicone oil tamponade (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200922) and nonvitrectomized eyes (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200923) were analyzed. Intravitreal aflibercept was administered according to guidelines. IOP was evaluated before and immediately after intravitreal injection (IVI) and at 5, 15, 30, 60, and 180\u00a0min, day 1, and week 1 postinjection. IOP measurements were taken with iCare-100 rebound tonometry (RBT) and Goldmann applanation tonometry (GAT). The mean participant age was 62.13\u2009\u00b1\u200914.06 years (male-to-female ratio, 1.48:1). Postinjection IOP increased to the same levels. IOP curve resolution was similar in all vitreous groups, showing no significant difference at any timepoints. Emulsified silicone oil did not affect the IOP curve. Prior IVI count had some influence on the dynamics of IOP spike resolution but did not affect the initial IOP rise. RBT showed moderate-to-good agreement with GAT, except for extremely elevated IOPs where it appeared less consistent. Intra-silicone and post-vitrectomy administration of aflibercept is safe. RBT may be considered for nonglaucomatous cases as an easy alternative to follow-up postinjection acute IOP changes.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-38455-1","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T12:20:41Z","timestamp":1771244441000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Acute effects of intravitreal aflibercept injections on intraocular pressure in vitrectomized and silicone-oil-filled eyes: a prospective cohort study"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4234-8041","authenticated-orcid":false,"given":"\u00c1ron","family":"Szab\u00f3","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9za","family":"Thury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00f3ra","family":"Baranyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferenc","family":"R\u00e1rosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00f3ra J.","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"Gale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edit","family":"T\u00f3th-Moln\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Kov\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"38455_CR1","doi-asserted-by":"publisher","first-page":"103390pharmaceu","DOI":"10.3390\/pharmaceutics11010009","volume":"11","author":"AK Rimpela","year":"2018","unstructured":"Rimpela, A. K., Kiiski, I., Deng, F., Kidron, H. & Urtti, A. Pharmacokinetic simulations of intravitreal biologicals: aspects of drug delivery to the posterior and anterior segments. Pharmaceutics 11, 103390pharmaceutics11010009 (2018).","journal-title":"Pharmaceutics"},{"key":"38455_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1159\/000446878","volume":"236","author":"H El Chehab","year":"2016","unstructured":"El Chehab, H., Agard, E., Russo, A., Boujnah, Y. & Dot, C. Intraocular pressure spikes after Aflibercept intravitreal injections. Ophthalmologica 236, 43\u201347. https:\/\/doi.org\/10.1159\/000446878 (2016).","journal-title":"Ophthalmologica"},{"key":"38455_CR3","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.2147\/OPTH.S414212","volume":"17","author":"SA LoBue","year":"2023","unstructured":"LoBue, S. A. et al. Clinical features associated with acute elevated intraocular pressure after intravitreal Anti-VEGF injections. Clin. Ophthalmol. 17, 1683\u20131690. https:\/\/doi.org\/10.2147\/OPTH.S414212 (2023).","journal-title":"Clin. Ophthalmol."},{"key":"38455_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2020.100862","author":"GB Melo","year":"2021","unstructured":"Melo, G. B. et al. Critical analysis of techniques and materials used in devices, syringes, and needles used for intravitreal injections. Prog Retin Eye Res. https:\/\/doi.org\/10.1016\/j.preteyeres.2020.100862 (2021).","journal-title":"Prog Retin Eye Res."},{"key":"38455_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-022-02536-2","author":"SB Garcia","year":"2022","unstructured":"Garcia, S. B. et al. Prevalence and implications of the presence of intraocular silicone oil droplets in patients treated with intravitreal injections of anti-VEGF. BMC Ophthalmol. https:\/\/doi.org\/10.1186\/s12886-022-02536-2 (2022).","journal-title":"BMC Ophthalmol."},{"key":"38455_CR6","doi-asserted-by":"publisher","first-page":"925","DOI":"10.2147\/OPTH.S32934","volume":"6","author":"DW Parke 3rd","year":"2012","unstructured":"Parke, D. W. 3rd., Sisk, R. A., Houston, S. K. & Murray, T. G. Ocular hypertension after intravitreal triamcinolone with vitrectomy and phacoemulsification. Clin. Ophthalmol. 6, 925\u201331. https:\/\/doi.org\/10.2147\/OPTH.S32934 (2012).","journal-title":"Clin. Ophthalmol."},{"key":"38455_CR7","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.oret.2022.10.008","volume":"7","author":"NS Patil","year":"2023","unstructured":"Patil, N. S. et al. Intravitreal steroids compared with anti-VEGF treatment for diabetic macular edema: A meta-analysis. Ophthalmol. Retina 7, 289\u2013299. https:\/\/doi.org\/10.1016\/j.oret.2022.10.008 (2023).","journal-title":"Ophthalmol. Retina"},{"key":"38455_CR8","doi-asserted-by":"publisher","first-page":"5221","DOI":"10.1167\/iovs.12-9702","volume":"53","author":"Y Xu","year":"2012","unstructured":"Xu, Y. et al. Ocular pharmacokinetics of bevacizumab in vitrectomized eyes with silicone oil tamponade. Invest. Ophthalmol. Vis. Sci. 53, 5221\u20135226. https:\/\/doi.org\/10.1167\/iovs.12-9702 (2012).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"38455_CR9","doi-asserted-by":"publisher","first-page":"913","DOI":"10.5301\/ejo.5000337","volume":"23","author":"ML Cascavilla","year":"2013","unstructured":"Cascavilla, M. L., Querques, G., Querques, L., Codenotti, M. & Bandello, F. Intravitreal Ranibizumab for myopic choroidal neovascularization after pars plana vitrectomy and silicone oil tamponade. Eur. J. Ophthalmol. 23, 913\u2013916. https:\/\/doi.org\/10.5301\/ejo.5000337 (2013).","journal-title":"Eur. J. Ophthalmol."},{"key":"38455_CR10","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/eye.2009.94","volume":"24","author":"KG Falavarjani","year":"2010","unstructured":"Falavarjani, K. G., Modarres, M. & Nazari, H. Therapeutic effect of bevacizumab injected into the silicone oil in eyes with neovascular glaucoma after vitrectomy for advanced diabetic retinopathy. Eye (Lond). 24, 717\u2013719. https:\/\/doi.org\/10.1038\/eye.2009.94 (2010).","journal-title":"Eye (Lond)"},{"key":"38455_CR11","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.survophthal.2024.09.006","volume":"70","author":"L Ferro Desideri","year":"2025","unstructured":"Ferro Desideri, L. et al. Evidence-based guidelines for drug dosing in intravitreal injections in silicone oil-filled eyes: Pharmacokinetics, safety, and optimal dosage. Surv. Ophthalmol. 70, 96\u2013105. https:\/\/doi.org\/10.1016\/j.survophthal.2024.09.006 (2025).","journal-title":"Surv. Ophthalmol."},{"key":"38455_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9103114","author":"SK Baek","year":"2020","unstructured":"Baek, S. K., Lee, M. W. & Lee, Y. H. Effect of Intrasilicone bevacizumab injection in diabetic tractional retinal detachment surgery: A retrospective case-control study. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm9103114 (2020).","journal-title":"J. Clin. Med."},{"key":"38455_CR13","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/s41433-021-01646-3","volume":"36","author":"R Chopra","year":"2022","unstructured":"Chopra, R. et al. Intravitreal injections: past trends and future projections within a UK tertiary hospital. Eye (Lond). 36, 1373\u20131378. https:\/\/doi.org\/10.1038\/s41433-021-01646-3 (2022).","journal-title":"Eye (Lond)"},{"key":"38455_CR14","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.ophtha.2017.01.001","volume":"124","author":"MD McLaughlin","year":"2017","unstructured":"McLaughlin, M. D. & Hwang, J. C. Trends in vitreoretinal procedures for Medicare Beneficiaries, 2000 to 2014. Ophthalmology 124, 667\u2013673. https:\/\/doi.org\/10.1016\/j.ophtha.2017.01.001 (2017).","journal-title":"Ophthalmology"},{"key":"38455_CR15","unstructured":"Shaarawy, T., Sherwood, M. & Grehn, F. WGA Guidelines on Design and Reporting of Glaucoma Surgical Trials (Kugler, 2009)."},{"key":"38455_CR16","doi-asserted-by":"publisher","unstructured":"European Glaucoma Society Terminology and Guidelines for Glaucoma, 5th Edition. Br. J. Ophthalmol. 105, 1-169 (2021). https:\/\/doi.org\/10.1136\/bjophthalmol-2021-egsguidelines","DOI":"10.1136\/bjophthalmol-2021-egsguidelines"},{"issue":"114","key":"38455_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bjophthalmol-2023-egsguidelines","volume":"107","author":"L Abegao Pinto","year":"2023","unstructured":"Abegao Pinto, L., Sunaric M\u00e9gevand, G. & Stalmans, I. European glaucoma Society: A guide on surgical innovation for glaucoma. Br. J. Ophthalmol. 107(114), 1. https:\/\/doi.org\/10.1136\/bjophthalmol-2023-egsguidelines (2023).","journal-title":"Br. J. Ophthalmol."},{"key":"38455_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000486145","volume":"239","author":"A Grzybowski","year":"2018","unstructured":"Grzybowski, A. et al. Update on intravitreal injections: Euretina expert consensus recommendations. Ophthalmologica 239, 181\u2013193. https:\/\/doi.org\/10.1159\/000486145 (2018).","journal-title":"Ophthalmologica"},{"key":"38455_CR19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1089\/jop.2010.0082","volume":"27","author":"EB Rodrigues","year":"2011","unstructured":"Rodrigues, E. B. et al. Effect of needle type and injection technique on pain level and vitreal reflux in intravitreal injection. J. Ocul Pharmacol. Ther. 27, 197\u2013203. https:\/\/doi.org\/10.1089\/jop.2010.0082 (2011).","journal-title":"J. Ocul Pharmacol. Ther."},{"key":"38455_CR20","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1097\/IJG.0000000000001894","volume":"30","author":"AM Levin","year":"2021","unstructured":"Levin, A. M., Chaya, C. J., Kahook, M. Y. & Wirostko, B. M. Intraocular pressure elevation following intravitreal Anti-VEGF injections: Short- and long-term considerations. J. Glaucoma 30, 1019\u20131026. https:\/\/doi.org\/10.1097\/IJG.0000000000001894 (2021).","journal-title":"J. Glaucoma"},{"key":"38455_CR21","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s00417-004-0898-7","volume":"242","author":"T Theelen","year":"2004","unstructured":"Theelen, T., Tilanus, M. A. & Klevering, B. J. Intraocular inflammation following endotamponade with high-density silicone oil. Graefes Arch. Clin. Exp. Ophthalmol. 242, 617\u2013620. https:\/\/doi.org\/10.1007\/s00417-004-0898-7 (2004).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"38455_CR22","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1097\/IAE.0000000000001651","volume":"38","author":"A Miele","year":"2018","unstructured":"Miele, A. et al. Ocular hypertension and glaucoma following vitrectomy: A systematic review. Retina 38, 883\u2013890. https:\/\/doi.org\/10.1097\/IAE.0000000000001651 (2018).","journal-title":"Retina"},{"key":"38455_CR23","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/ICU.0000000000000913","volume":"34","author":"AM Elhusseiny","year":"2023","unstructured":"Elhusseiny, A. M. & Sallam, A. B. Cataract surgery in adult eyes with short axial length. Curr. Opin. Ophthalmol. 34, 84\u201393. https:\/\/doi.org\/10.1097\/ICU.0000000000000913 (2023).","journal-title":"Curr. Opin. Ophthalmol."},{"key":"38455_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-021-02104-0","author":"Z Qian","year":"2021","unstructured":"Qian, Z. et al. Detection of shallow anterior chamber depth from two-dimensional anterior segment photographs using deep learning. BMC Ophthalmol. https:\/\/doi.org\/10.1186\/s12886-021-02104-0 (2021).","journal-title":"BMC Ophthalmol."},{"key":"38455_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-017-0417-3","author":"S Jeong","year":"2017","unstructured":"Jeong, S., Sagong, M. & Chang, W. Acute angle closure attack after an intravitreal bevacizumab injection for branch retinal vein occlusion: a case report. BMC Ophthalmol. https:\/\/doi.org\/10.1186\/s12886-017-0417-3 (2017).","journal-title":"BMC Ophthalmol."},{"key":"38455_CR26","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/s0002-9394(98)00436-x","volume":"127","author":"CB Toris","year":"1999","unstructured":"Toris, C. B., Yablonski, M. E., Wang, Y. L. & Camras, C. B. Aqueous humor dynamics in the aging human eye. Am. J. Ophthalmol. 127, 407\u2013412. https:\/\/doi.org\/10.1016\/s0002-9394(98)00436-x (1999).","journal-title":"Am. J. Ophthalmol."},{"key":"38455_CR27","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jcjo.2022.06.002","volume":"58","author":"R Sachdeva","year":"2023","unstructured":"Sachdeva, R., Iordanous, Y. & Lin, T. Comparison of intraocular pressure measured by iCare tonometers and Goldmann applanation tonometer. Can. J. Ophthalmol. 58, 426\u2013432. https:\/\/doi.org\/10.1016\/j.jcjo.2022.06.002 (2023).","journal-title":"Can. J. Ophthalmol."},{"key":"38455_CR28","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00417-007-0758-3","volume":"246","author":"S Munkwitz","year":"2008","unstructured":"Munkwitz, S., Elkarmouty, A., Hoffmann, E. M., Pfeiffer, N. & Thieme, H. Comparison of the iCare rebound tonometer and the Goldmann applanation tonometer over a wide IOP range. Graefes Arch. Clin. Exp. Ophthalmol. 246, 875\u2013879. https:\/\/doi.org\/10.1007\/s00417-007-0758-3 (2008).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"38455_CR29","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1001\/jamaophthalmol.2014.867","volume":"132","author":"ML Zhang","year":"2014","unstructured":"Zhang, M. L. et al. Single vs multiple intraocular pressure measurements in glaucoma surgical trials. JAMA Ophthalmol. 132, 956\u2013962. https:\/\/doi.org\/10.1001\/jamaophthalmol.2014.867 (2014).","journal-title":"JAMA Ophthalmol."},{"key":"38455_CR30","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/j.1444-0938.2008.00298.x","volume":"91","author":"TM AlMubrad","year":"2008","unstructured":"AlMubrad, T. M. & Ogbuehi, K. C. The effect of repeated applanation on subsequent IOP measurements. Clin. Exp. Optom. 91, 524\u2013529. https:\/\/doi.org\/10.1111\/j.1444-0938.2008.00298.x (2008).","journal-title":"Clin. Exp. Optom."},{"key":"38455_CR31","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3109\/02713681003678824","volume":"35","author":"DD Gaton","year":"2010","unstructured":"Gaton, D. D. et al. Effect of repeated applanation tonometry on the accuracy of intraocular pressure measurements. Curr. Eye Res. 35, 475\u2013479. https:\/\/doi.org\/10.3109\/02713681003678824 (2010).","journal-title":"Curr. Eye Res."},{"key":"38455_CR32","doi-asserted-by":"publisher","first-page":"e360","DOI":"10.1097\/IJG.0000000000001879","volume":"30","author":"E Meduri","year":"2021","unstructured":"Meduri, E., Gillmann, K. & Mansouri, K. Intraocular pressure variations after intravitreal injections measured with an implanted suprachoroidal telemetry sensor. J. Glaucoma. 30, e360\u2013e363. https:\/\/doi.org\/10.1097\/IJG.0000000000001879 (2021).","journal-title":"J. Glaucoma"},{"key":"38455_CR33","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1034\/j.1600-0420.1998.760518.x","volume":"76","author":"OF Recep","year":"1998","unstructured":"Recep, O. F., Hasiripi, H., Vayisoglu, E., Kalayci, D. & Sarikatipoglu, H. Accurate time interval in repeated tonometry. Acta Ophthalmol. Scand. 76, 603\u2013605. https:\/\/doi.org\/10.1034\/j.1600-0420.1998.760518.x (1998).","journal-title":"Acta Ophthalmol. Scand."},{"key":"38455_CR34","doi-asserted-by":"publisher","first-page":"79","DOI":"10.18240\/ijo.2020.01.12","volume":"13","author":"A Sternfeld","year":"2020","unstructured":"Sternfeld, A., Ehrlich, R., Weinberger, D. & Dotan, A. Effect of different lens status on intraocular pressure elevation in patients treated with anti-vascular endothelial growth factor injections. Int. J. Ophthalmol. 13, 79\u201384. https:\/\/doi.org\/10.18240\/ijo.2020.01.12 (2020).","journal-title":"Int. J. Ophthalmol."},{"key":"38455_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10173860","author":"P Brusini","year":"2021","unstructured":"Brusini, P., Salvetat, M. L. & Zeppieri, M. How to measure intraocular pressure: An updated review of various tonometers. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm10173860 (2021).","journal-title":"J. Clin. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38455-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38455-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38455-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:19:20Z","timestamp":1781633960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38455-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["38455"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-38455-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"18 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Ethics Committee of the University of Szeged reviewed and approved the trial (Protocol no. NH_SiOP-001, Reference no. 168\/2022-SZTE RKEB). The study was conducted in accordance with the Helsinki Declaration of 1964, and its later amendments. All subjects provided informed consent to participate in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"9319"}}